In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein (original) (raw)
<em>In Vitro</em> Aggregation Assays Using Hyperphosphorylated Tau Protein
Dexin Sui
Journal of Visualized Experiments, 2015
View PDFchevron_right
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
Goran Simic
Biomolecules, 2016
View PDFchevron_right
Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies
Nahuai Badiola
CNS & Neurological Disorders - Drug Targets, 2010
View PDFchevron_right
Development of Tau Aggregation Inhibitors for Alzheimer's Disease
Herbert Waldmann, Boris Schmidt
Angewandte Chemie International Edition, 2009
View PDFchevron_right
Tau Aggregation Inhibitors: The Future of Alzheimer's Pharmacotherapy?
B. Imbimbo
Expert opinion on pharmacotherapy, 2016
View PDFchevron_right
Peptide-based inhibitors of Tau aggregation as a potential therapeutic for Alzheimer’s disease and other Tauopathies
Shreyasi Chatterjee
2021
View PDFchevron_right
Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions
Dexin Sui
Scientific Reports, 2020
View PDFchevron_right
Mechanisms of Tau Self-Aggregation and Neurotoxicity
Gonzalo Farias
Current Alzheimer Research, 2011
View PDFchevron_right
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms: Pathology of non-mutant tau in transgenic mice
Karen Espinoza
Journal of Neurochemistry, 2003
View PDFchevron_right
Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death
Dexin Sui
Molecular Neurobiology, 2020
View PDFchevron_right
Tau Aggregation in Alzheimer's Disease
Nathalie Sibille
Prion, 2007
View PDFchevron_right
Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
Thomas Wisniewski
Gerontology, 2014
View PDFchevron_right
Formation of Filamentous Tau Aggregations in Transgenic Mice Expressing V337M Human Tau
Tsutomu Hashikawa
Neurobiology of Disease, 2001
View PDFchevron_right
Tau modifiers as therapeutic targets for Alzheimer's disease
Atsushi Takeda
… et Biophysica Acta (BBA …, 2005
View PDFchevron_right
Tau oligomers and aggregation in Alzheimer’s disease
Martha Adriana De Anda-Hernández
Journal of Neurochemistry, 2010
View PDFchevron_right
Human Tau Isoform Aggregation and Selective Detection of Misfolded Tau from Post-Mortem Alzheimer’s Disease Brains
Wenquan Zou
2020
View PDFchevron_right
Cellular Models of Aggregation-Dependent Template-Directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer's Disease
Janet Rickard
The Journal of biological chemistry, 2015
View PDFchevron_right
Pseudophosphorylation of tau protein alters its ability for self-aggregation: Pseudo-phosphorylated tau aggregation
Max Holzer
Journal of Neurochemistry, 2004
View PDFchevron_right
Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer’s disease?
Francisco Garcia-Sierra
Future Neurology, 2009
View PDFchevron_right
Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy: AGGREGATION IS TOXIC TO CELLS BUT CAN BE REVERSED BY INHIBITOR DRUGS
Zuzana Gazova
Journal of Biological Chemistry, 2006
View PDFchevron_right
A Novel Perspective on Tau in Alzheimers Disease
George Perry
Current Alzheimer Research, 2011
View PDFchevron_right
Role of tau in Alzheimer’s dementia and other neurodegenerative diseases
Ghania Ait-Ghezala
View PDFchevron_right
Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors
Maria Joseph
Neurobiology of Aging, 2013
View PDFchevron_right
Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model
Kunie Ando
Biochemical Society Transactions, 2010
View PDFchevron_right
Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity
satish kumar
The Journal of biological chemistry, 2014
View PDFchevron_right
Identification of the Tau phosphorylation pattern that drives its aggregation
Guy LIPPENS
Proceedings of the National Academy of Sciences, 2017
View PDFchevron_right
The Role of Tau in Alzheimer's Disease and Related Disorders: Role of Tau in AD and Related Disorders
Frank LaFerla
Cns Neuroscience & Therapeutics - CNS NEUROSCI THER, 2010
View PDFchevron_right
The Role of Tau in Alzheimer's Disease and Related Disorders
Rodrigo Medeiros
CNS Neuroscience & Therapeutics, 2010
View PDFchevron_right
Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau
Khalid Iqbal
Journal of Neural Transmission, 2005
View PDFchevron_right
Screening of Tau Protein Kinase Inhibitors in a Tauopathy-relevant cell-based model of Tau Hyperphosphorylation and Oligomerization
Richard Yost
View PDFchevron_right
Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity
Ashim Paul
Scientific Reports
View PDFchevron_right
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
Andrei Leonov, Sybille Krauss
Acta neuropathologica, 2015
View PDFchevron_right
Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model
Kunie Ando
The American Journal of Pathology, 2011
View PDFchevron_right